Philip is a Sr. Business Analyst based in Lifescience Dynamics’ HQ in London. Philip holds a PhD from Imperial College London, where he developed platform processes to improve the manufacture of biosimilars. He holds an MEng in Chemical Engineering from Imperial College London. As a research associate at Imperial College London he used computational tools to optimise production processes of biologics in co-operation with MedImmune.
He has gathered CI experience spanning a number of indications from rare diseases, to work on global top 10 assets through primary and secondary work. His expertise is in CI monitoring projects with a focus on blockbuster assets, as well as anti-infectives.
Philip is fluent in English, German and Polish.